- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Nebraska Medicaid Expansion; Sepsis Study Pushback; Clover Health Expands
Nebraska voters will decide on Medicaid expansion in November; a medical watchdog has called for a stop to a clinical trial for sepsis treatment; Medicare Advantage insurer Clover Health is expanding its health plans to 6 new markets.
Nebraska Puts Medicaid Expansion on the Ballot
A campaign to get Medicaid expansion on the ballot in Nebraska this November met all of its requirements, giving voters the decision to expand Medicaid to nearly 90,000 individuals. According to The Hill, Insure the Good Life, the ballot initiative committee, obtained 104,477 valid signatures, exceeding the signature requirement by more than 20,000. Nebraska marks the fourth state this year preparing to put Medicaid expansion on the ballot in November.
Medical Watchdog Calls for End to Sepsis Trial
As the National Institutes of Health continues to enroll patients in a clinical trial of sepsis treatment, medical watchdog Public Citizen is calling for the immediate halt of enrollment. The watchdog is also calling for an investigation into how the study received approval, arguing that it puts patients at risk of serious harm, STAT News reported. In a letter, it says the study's protocol is so "fundamentally flawed" that it will not produce reliable results.
Clover Health Launching MA Plan in 6 New Markets
Medicare Advantage (MA) insurer Clover Health announced a significant expansion with plans to enter 6 new markets in 2019. In the coming year, it will be offering its MA plans in El Paso, Texas; Camden, New Jersey; Charleston, South Carolina; Nashville, Tennessee; Philadelphia, Pennsylvania; and Tucson, Arizona. Clover Health also released results showing its technology has an 85% accuracy rate in identifying patients at risk of being admitted to the hospital in the next 28 days.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
